Automatic Generation of Validated Specific Epitope Sets - PubMed (original) (raw)

Automatic Generation of Validated Specific Epitope Sets

Sebastian Carrasco Pro et al. J Immunol Res. 2015.

Abstract

Accurate measurement of B and T cell responses is a valuable tool to study autoimmunity, allergies, immunity to pathogens, and host-pathogen interactions and assist in the design and evaluation of T cell vaccines and immunotherapies. In this context, it is desirable to elucidate a method to select validated reference sets of epitopes to allow detection of T and B cells. However, the ever-growing information contained in the Immune Epitope Database (IEDB) and the differences in quality and subjects studied between epitope assays make this task complicated. In this study, we develop a novel method to automatically select reference epitope sets according to a categorization system employed by the IEDB. From the sets generated, three epitope sets (EBV, mycobacteria and dengue) were experimentally validated by detection of T cell reactivity ex vivo from human donors. Furthermore, a web application that will potentially be implemented in the IEDB was created to allow users the capacity to generate customized epitope sets.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Diagram of the filtering steps towards the generation of the validated sets of epitopes, including the number of epitopes found in each step.

Figure 2

Figure 2

(a) Web application main page interface. (b) Web application “advanced options” page interface.

Figure 3

Figure 3

Predicted epitope pools induce a detectable ex vivo cytokine response. PBMC from donors with LTBI (MTB donor) or previously exposed to DENV were stimulated with their respective epitope pools and an EBV epitope pool. After ex vivo stimulation, the IFN_γ_ response was measured by ICS using flow cytometry. Gating strategy (a) and representative plots of the responses for both CD4+ and CD8+ T cells are shown for a MTB donor (b) and DENV donor (c). (d) The ICS IFN_γ_ responses induced by each epitope pool for all donors tested are summarized (n = 10). Statistical difference was determined using a one-tailed Mann-Whitney test. (∗ P ≤ 0.05; ∗∗ P ≤ 0.01).

Similar articles

Cited by

References

    1. Madden D. R. The three-dimensional structure of peptide-MHC complexes. Annual Review of Immunology. 1995;13:587–622. doi: 10.1146/annurev.iy.13.040195.003103. - DOI - PubMed
    1. Neefjes J., Jongsma M. L. M., Paul P., Bakke O. Towards a systems understanding of MHC class i and MHC class II antigen presentation. Nature Reviews Immunology. 2011;11(12):823–836. doi: 10.1038/nri3084. - DOI - PubMed
    1. Kurts C., Robinson B. W., Knolle P. A. Cross-priming in health and disease. Nature Reviews Immunology. 2010;10(6):403–414. doi: 10.1038/nri2780. - DOI - PubMed
    1. Borish L. Genetics of allergy and asthma. Annals of Allergy, Asthma & Immunology. 1999;82(5):413–426. doi: 10.1016/s1081-1206(10)62715-9. - DOI - PubMed
    1. Andrieu J.-M., Chen S., Lai C., Guo W., Lu W. Mucosal SIV vaccines comprising inactivated virus particles and bacterial adjuvants induce CD8+ T-regulatory cells that suppress SIV-positive CD4+ T-cell activation and prevent SIV infection in the macaque model. Frontiers in Immunology. 2014;5, article 297 doi: 10.3389/fimmu.2014.00297. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources